Dyadic to Present at Rodman & Renshaw Conference

Dyadic International, Inc. (AMEX: DIL), a biotechnology
company engaged in the development, manufacture and sale of biological
products, today announced that its President and CEO, Mark Emalfarb,
will present at the Rodman & Renshaw Techvest 7th Annual Healthcare
Conference. The presentation is scheduled to take place at 4:35 p.m.
EST on Tuesday, November 8, 2005, at the New York Palace Hotel in New
York, NY.

   About Dyadic

   Dyadic International, Inc., is engaged in the development,
manufacture and sale of biological products (proteins, enzymes,
peptides and other bio-molecules), as well as the licensing of its
enabling proprietary technology to business collaborators for the
discovery, development and manufacture of biological products from
genes. Dyadic markets its products and services for applications in
the textile, chemical, agricultural, pulp & paper, pharmaceutical,
biotechnology and other industries, using its proprietary C1 Host
Technology and C1 Expression and Screening Systems for the discovery,
development and production of biological products.

   Cautionary Statement for Forward-Looking Statements

   Certain statements contained in this press release are
"forward-looking statements." These forward-looking statements involve
risks and uncertainties that could cause our actual results,
performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of charge
on the SEC's web site at http://www.sec.gov, including our Annual
Report on Form 10-KSB for the year ended December 31, 2004, and our
Quarterly Report for the quarter ended June 30, 2005 on Form 10-QSB.
Except as required by law, we expressly disclaim any intent or
obligation to update any forward-looking statements.